MedPath

Identification of biomarkers in patients with malignant pleural mesothelioma undergoing chemotherapy

Not Applicable
Recruiting
Conditions
mesothelioma
Cancer - Lung - Mesothelioma
Registration Number
ACTRN12614000027617
Lead Sponsor
Asbestos Diseases Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
130
Inclusion Criteria

pathological diagnosis of malignant pleural mesothelioma
- about to commence on chemotherapy of choice by the treating physician - including first line, second line or experimental regimens
- ability to give informed consent

Exclusion Criteria

Other malignancies requiring active treatments

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath